- Home
- VREX vs ARVN Comparison
VREX vs ARVN Comparison
Compare VREX & ARVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VREX
- ARVN
- Stock Information
- Founded
- VREX 2016
- ARVN 2015
- Country
- VREX United States
- ARVN United States
- Employees
- VREX N/A
- ARVN N/A
- Industry
- VREX Industrial Machinery/Components
- ARVN Biotechnology: Pharmaceutical Preparations
- Sector
- VREX Technology
- ARVN Health Care
- Exchange
- VREX Nasdaq
- ARVN Nasdaq
- Market Cap
- VREX 443.9M
- ARVN 456.2M
- IPO Year
- VREX N/A
- ARVN 2018
- Fundamental
- Price
- VREX $11.62
- ARVN $7.32
- Analyst Decision
- VREX Strong Buy
- ARVN Buy
- Analyst Count
- VREX 2
- ARVN 22
- Target Price
- VREX $19.50
- ARVN $20.21
- AVG Volume (30 Days)
- VREX 555.4K
- ARVN 2.0M
- Earning Date
- VREX 08-07-2025
- ARVN 08-06-2025
- Dividend Yield
- VREX N/A
- ARVN N/A
- EPS Growth
- VREX N/A
- ARVN N/A
- EPS
- VREX N/A
- ARVN N/A
- Revenue
- VREX $821,400,000.00
- ARVN $372,800,000.00
- Revenue This Year
- VREX $5.01
- ARVN $7.57
- Revenue Next Year
- VREX $2.97
- ARVN N/A
- P/E Ratio
- VREX N/A
- ARVN N/A
- Revenue Growth
- VREX N/A
- ARVN 299.57
- 52 Week Low
- VREX $6.76
- ARVN $5.90
- 52 Week High
- VREX $16.93
- ARVN $29.61
- Technical
- Relative Strength Index (RSI)
- VREX 81.85
- ARVN 52.39
- Support Level
- VREX $10.63
- ARVN $6.96
- Resistance Level
- VREX $11.39
- ARVN $7.30
- Average True Range (ATR)
- VREX 0.65
- ARVN 0.39
- MACD
- VREX 0.27
- ARVN 0.06
- Stochastic Oscillator
- VREX 93.84
- ARVN 71.19
About VREX Varex Imaging Corporation
Varex Imaging Corp designs and manufactures X-ray imaging components. It operates in two segments Medical and Industrial. The Medical segment, which is the key revenue driver, designs, manufactures, sells, and services X-ray imaging components, including X-ray tubes, digital detectors and accessories, generators, and heat exchangers among other products. The Industrial segment designs, manufactures, sells, and services Linatron X-ray accelerators, X-ray tubes, digital flat panel detectors, high-voltage connectors, and coolers. Geographically, the company generates maximum revenue from Europe, Middle East, and Africa (EMEA) and the rest from the Americas and Asia Pacific region.
About ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.